Literature DB >> 25104865

The importance of bone marrow involvement in GVHD.

Caroline A Lindemans1, Alan M Hanash1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25104865      PMCID： PMC4126324          DOI： 10.1182/blood-2014-06-576991

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

Review 1.  The lung as a target organ of graft-versus-host disease.

Authors:  Gregory Yanik; Kenneth R Cooke
Journal:  Semin Hematol       Date:  2006-01       Impact factor: 3.851

2.  Megadose CD34(+) cell grafts improve recovery of T cell engraftment but not B cell immunity in patients with severe combined immunodeficiency disease undergoing haplocompatible nonmyeloablative transplantation.

Authors:  Christopher C Dvorak; Giun-Yi Hung; Biljana Horn; Elizabeth Dunn; Ching-Ying Oon; Morton J Cowan
Journal:  Biol Blood Marrow Transplant       Date:  2008-10       Impact factor: 5.742

3.  Bone marrow graft-versus-host disease: early destruction of hematopoietic niche after MHC-mismatched hematopoietic stem cell transplantation.

Authors:  Yusuke Shono; Satoshi Ueha; Yong Wang; Jun Abe; Makoto Kurachi; Yoshihiro Matsuno; Tatsuki Sugiyama; Takashi Nagasawa; Masahiro Imamura; Kouji Matsushima
Journal:  Blood       Date:  2010-03-30       Impact factor: 22.113

4.  The central nervous system is a target of acute graft versus host disease in mice.

Authors:  Steffen Hartrampf; Jarrod A Dudakov; Linda K Johnson; Odette M Smith; Jennifer Tsai; Natalie V Singer; Mallory L West; Alan M Hanash; Michael H Albert; Bingfang Liu; Miklos Toth; Marcel R M van den Brink
Journal:  Blood       Date:  2013-01-08       Impact factor: 22.113

5.  Thymic atrophy in murine acute graft-versus-host disease is effected by impaired cell cycle progression of host pro-T and pre-T cells.

Authors:  W Krenger; S Rossi; L Piali; G A Holländer
Journal:  Blood       Date:  2000-07-01       Impact factor: 22.113

Review 6.  Concise review: the bone marrow niche as a target of graft versus host disease.

Authors:  Malte von Bonin; Martin Bornhäuser
Journal:  Stem Cells       Date:  2014-06       Impact factor: 6.277

Review 7.  B-cell reconstitution for SCID: should a conditioning regimen be used in SCID treatment?

Authors:  Elie Haddad; Sandrine Leroy; Rebecca H Buckley
Journal:  J Allergy Clin Immunol       Date:  2013-03-05       Impact factor: 10.793

8.  Immune reconstitution in patients with Fanconi anemia after allogeneic bone marrow transplantation.

Authors:  Miriam Perlingeiro Beltrame; Mariester Malvezzi; Carmem Bonfim; Dimas Tadeu Covas; Alberto Orfao; Ricardo Pasquini
Journal:  Cytotherapy       Date:  2014-05-13       Impact factor: 5.414

9.  Bone marrow T-cell infiltration during acute GVHD is associated with delayed B-cell recovery and function after HSCT.

Authors:  Angela Mensen; Korinna Jöhrens; Ioannis Anagnostopoulos; Sonya Demski; Maike Oey; Andrea Stroux; Philipp Hemmati; Jörg Westermann; Olga Blau; Friedrich Wittenbecher; Kamran Movassaghi; Martin Szyska; Sybill Thomas; Bernd Dörken; Carmen Scheibenbogen; Renate Arnold; Il-Kang Na
Journal:  Blood       Date:  2014-05-15       Impact factor: 22.113

10.  Bone marrow graft-versus-host disease: evaluation of its clinical impact on disrupted hematopoiesis after allogeneic hematopoietic stem cell transplantation.

Authors:  Yusuke Shono; Souichi Shiratori; Mizuha Kosugi-Kanaya; Satoshi Ueha; Junichi Sugita; Akio Shigematsu; Takeshi Kondo; Daigo Hashimoto; Katsuya Fujimoto; Tomoyuki Endo; Mitsufumi Nishio; Satoshi Hashino; Yoshihiro Matsuno; Kouji Matsushima; Junji Tanaka; Masahiro Imamura; Takanori Teshima
Journal:  Biol Blood Marrow Transplant       Date:  2013-12-27       Impact factor: 5.742
  10 in total
  4 in total

1.  Prophylaxis of acute graft-versus-host disease by CCR5 blockade combined with cyclosporine A in a murine model.

Authors:  Jing Yuan; Han-yun Ren; Yong-jin Shi; Wei Liu
Journal:  Inflamm Res       Date:  2015-01-04       Impact factor: 4.575

2.  The gut microbial metabolite trimethylamine N-oxide aggravates GVHD by inducing M1 macrophage polarization in mice.

Authors:  Kunpeng Wu; Yan Yuan; Huihui Yu; Xin Dai; Shu Wang; Zhengxu Sun; Fen Wang; He Fei; Qiwang Lin; Hua Jiang; Tong Chen
Journal:  Blood       Date:  2020-07-23       Impact factor: 22.113

3.  CD40 Activity on Mesenchymal Cells Negatively Regulates OX40L to Maintain Bone Marrow Immune Homeostasis Under Stress Conditions.

Authors:  Barbara Bassani; Claudio Tripodo; Paola Portararo; Alessandro Gulino; Laura Botti; Claudia Chiodoni; Elena Jachetti; Niccolò Bolli; Marilena Ciciarello; Korinna Joehrens; Ioannis Anagnostopoulos; Il-Kang Na; Antonio Curti; Mario P Colombo; Sabina Sangaletti
Journal:  Front Immunol       Date:  2021-05-18       Impact factor: 7.561

4.  Conditioning with Fludarabine-Busulfan versus Busulfan-Cyclophosphamide Is Associated with Lower aGVHD and Higher Survival but More Extensive and Long Standing Bone Marrow Damage.

Authors:  Xin He; YongBin Ye; XiaoJun Xu; Jing Wang; YuXian Huang; GuangYang Weng; MingWan Zhang; KunYuan Guo
Journal:  Biomed Res Int       Date:  2016-10-24       Impact factor: 3.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.